MIRTAZAPINE 30 MG - Resultados de la búsqueda

Bélgica - francés - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

mirtazapine sandoz 30 mg compr. orodisp.

sandoz sa-nv - mirtazapine 30 mg - comprimé orodispersible - 30 mg - mirtazapine 30 mg - mirtazapine

Reino Unido - inglés - MHRA (Medicines & Healthcare Products Regulatory Agency)

mirtazapine 30mg tablets

arrow generics ltd - mirtazapine - oral tablet - 30mg

Reino Unido - inglés - MHRA (Medicines & Healthcare Products Regulatory Agency)

mirtazapine 30mg tablets

ennogen healthcare ltd - mirtazapine - oral tablet - 30mg

Estados Unidos - inglés - NLM (National Library of Medicine)

mirtazapine tablet, film coated

cardinal health - mirtazapine (unii: a051q2099q) (mirtazapine - unii:a051q2099q) - mirtazapine 30 mg - mirtazapine tablets, usp are indicated for the treatment of major depressive disorder. the efficacy of mirtazapine in the treatment of major depressive disorder was established in 6-week controlled trials of outpatients whose diagnoses corresponded most closely to the diagnostic and statistical manual of mental disorders-3rd edition (dsm-iii) category of major depressive disorder (see clinical pharmacology). a major depressive episode (dsm-iv) implies a prominent and relatively persistent (nearly every day for at least 2 weeks) depressed or dysphoric mood that usually interferes with daily functioning, and includes at least 5 of the following 9 symptoms: depressed mood, loss of interest in usual activities, significant change in weight and/or appetite, insomnia or hypersomnia, psychomotor agitation or retardation, increased fatigue, feelings of guilt or worthlessness, slowed thinking or impaired concentration, a suicide attempt, or suicidal ideation. the effectiveness of mirtazapine

Estados Unidos - inglés - NLM (National Library of Medicine)

mirtazapine tablet, film coated

direct rx - mirtazapine (unii: a051q2099q) (mirtazapine - unii:a051q2099q) - mirtazapine 30 mg - mirtazapine tablets, usp are indicated for the treatment of major depressive disorder. the efficacy of mirtazapine tablets, usp in the treatment of major depressive disorder was established in six week controlled trials of outpatients whose diagnoses corresponded most closely to the diagnostic and statistical manual of mental disorders – 3rd edition (dsm-iii) category of major depressive disorder (see clinical pharmacology). a major depressive episode (dsm-iv) implies a prominent and relatively persistent (nearly every day for at least 2 weeks) depressed or dysphoric mood that usually interferes with daily functioning, and includes at least five of the following nine symptoms: depressed mood, loss of interest in usual activities, significant change in weight and/or appetite, insomnia or hypersomnia, psychomotor agitation or retardation, increased fatigue, feelings of guilt or worthlessness, slowed thinking or impaired concentration, a suicide attempt or suicidal ideation. the effectiveness of

Reino Unido - inglés - MHRA (Medicines & Healthcare Products Regulatory Agency)